TNFSF9 and neoplasm: The electroporation of DCs with mRNA encoding 4-1BB ligand (4-1BBL) [206], CD83 [207], tumour necrosis factor receptor superfamily member 4 (TNFRSF4) [208], p53 [209] and CD133 [210] all primed anti-tumor CTLs.